Maintain hMSC Multipotency After Large Scale Expansion
Source: Thermo Fisher Scientific
By S. Carter, J. Granchelli, and T. Stelzer
Whether the requirements are for clinical or research use, obtaining a substantial number of cells can constitute a bottleneck for the investigator. hMSC are good candidates because they are readily expanded in culture, have immunomodulatory potential and can differentiate into the osteogenic, chondrogenic, and adipogenic lineages.
access the Application Note!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more